Skip to main content
Equibles

CAMLINFINE · Camlin Fine Sciences Limited

Use CAMLINFINE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CAMLINFINE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
76.87 INR -3.05 (-3.82%) At close · Nov 13
Rebalance outlook locked
Market Cap
14.77B INR
Shares
192.10M
Volume · Nov 13 453.8K Avg daily vol (3M) 1.03M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close76.87 INR Open79.74 INR Day76.50–79.74 INR 52W close74.15–177.37 INR Avg vol 30d858K Last earningsNov 3, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 3
Earnings call
Rights issue targets liquidity as Q2 EBITDA margin falls

Cameron Fine Sciences Limited approved a rights issue of 250 crores to stabilize working capital and support growth. Q2 EBITDA margin fell from 3.4% to 0.5%; management expects Q4 revenue of 600 crores and EBITDA of 60 crore plus.

5 source passages
Cameron Fine Sciences Limited Q2 and H1 FY27 Mornings Conference Call. At 250 crores, you can see we have not yet decided on the pricing. Obviously, this purpose of the issue is for augmenting working capital. this has percolated down and eaten up our EBITDA, which anyway was 3.4% has almost come down to 0.5% in this quarter. The turnaround, we expect the top line to be 600 crores, and the EBITDA to be 60 crore plus in Q4. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲12.3% 4.33B INR −41.36M INR '25 Q3 ▲8.9% 4.37B INR −7.24M INR '25 Q4 ▲7% 4.24B INR −99.61M INR '26 Q1 ▲8.7% 4.60B INR −143.84M INR '26 Q2 ▲5.5% 4.57B INR −362.30M INR '26 Q3 ▼2.9% 4.25B INR 882.02M INR '26 Q4 ▲22.7% 5.20B INR −317.06M INR '27 Q1 LATEST ▲6.9% 4.91B INR −278.54M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 74.15 INR Now 76.87 INR · 3% Range high 177.37 INR
vs 200-day avg -35% vs 50-day avg -16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:CAMLINFINE +1.1% -14.1% -36.3% -8.6% -48.2%

Exchange listing

Market
XNSE
Ticker
CAMLINFINE
ISIN
INE052I01032
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.camlinfs.com/
Investor relations
https://www.camlinfs.com/investor-relations

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2016-07-28 0.45 INR
2015-07-27 0.45 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-03 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-11 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-26 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026
  • Earnings call · Q3 2026 2026-02-13
    Investor Q3 2026 Call Recording 13.02.2026